Genetic markers for ACE inhibitor associated angioedema

Not Applicable

• Conditions: Angioedema - ACE inhibitor associated; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12611000188932
• Lead Sponsor: Royal Adelaide Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

patients with a history of ACE inhibitor associated angioedema

Exclusion Criteria

angioedema due to other pathology ie C1 esterase inhibitor defiency, food or other drug allergy

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
frequency of single nucleotide polymorphism C-2339A of XPNPEP2 gene[This is a genetic study, looking a genetic variants between the study groups. As such, the outcome for each patient will only be measured once in the course of the study, as it is not expected that the genetic findings will vary over time.]

Secondary Outcome Measures

Name	Time	Method
nil[nil]